Alise Reicin - Dec 4, 2024 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Role: Chief Executive Officer, Director
Signature: /s/ Daniel Lochner, Attorney-in-Fact
Stock symbol: TECX
Transactions as of: Dec 4, 2024
Transactions value $: $0
Form type: 4
Date filed: 12/6/2024, 05:19 PM
Previous filing: Jun 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TECX	Common Stock	Award	$0	+11.7K	+7.03%	$0.00	178K	Dec 4, 2024	Direct	F1, F2
holding	TECX	Common Stock						125K	Dec 4, 2024	By Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECX	Employee Stock Option (Right to Buy)	Award	$0	+6K		$0.00	6K	Dec 4, 2024	Common Stock	6K	$51.28	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 4 equal annual installments with the first installment vesting on June 20, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2	4,079 of these shares are subject to vesting and a repurchase right in favor of the Issuer. Such repurchase right will lapse on December 31, 2024 so long as the Reporting Person continues to provide service to the Issuer on such vesting date.
F3	These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voting and dispositive power over the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	The shares subject to the option vest as to 25% of the shares on June 20, 2025 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service to the Issuer on each such vesting date.